학술논문

Low Baseline IsoPSA Index is Associated With a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men With an Elevated PSA
Document Type
Article
Source
In Urology July 2025 201:69-75
Subject
ONC
Language
ISSN
0090-4295
Abstract
Conclusion The risk of developing csPCa was smaller in patients with initial low vs high IsoPSA Indices over the ensuing 30 months, which supports using IsoPSA to safely avoid follow-up testing.